Modalités d'administration de l'irinotecan dans le traitement du cancer colorectal métastatique = Irinotecan for the treatment of metastatic colorectal cancerASSENAT, Eric; DUFFOUR, Jacqueline; YCHOU, Marc et al.Bulletin du cancer. 2006, Vol 93, Num 5, pp 507-515, issn 0007-4551, 9 p.Article

Safety of cisplatin combined with continuous 5-FU versus bolus 5-FU and leucovorin, in metastatic gastrointestinal cancer (FFCD 9404 randomised trial)DUFFOUR, Jacqueline; BOUCHE, Olivier; RAOUL, Jean-Luc et al.Anticancer research. 2006, Vol 26, Num 5B, pp 3877-3883, issn 0250-7005, 7 p.Article

MR Volumetric Measurement of Low Rectal Cancer Helps Predict Tumor Response and Outcome after Combined Chemotherapy and Radiation TherapyNOUGARET, Stephanie; ROUANET, Philippe; REINHOLD, Caroline et al.Radiology. 2012, Vol 263, Num 2, pp 409-418, issn 0033-8419, 10 p.Article

Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimenYCHOU, Marc; DUFFOUR, Jacqueline; KRAMAR, Andrew et al.Cancer chemotherapy and pharmacology. 2003, Vol 52, Num 4, pp 282-290, issn 0344-5704, 9 p.Article

Inter-observer agreement between dermatologists and oncologists in assessing dermatological toxicities in patients with metastatic colorectal cancer treated by cetuximab-based chemotherapies: A pilot comparative studyDUFFOUR, Jacqueline; THEZENAS, Simon; YCHOU, Marc et al.European journal of cancer (1990). 2010, Vol 46, Num 18, pp 3169-3174, issn 0959-8049, 6 p.Article

Pharmacokinetics and pharmacodynamics of irinotecan and its metabolites from plasma and saliva data in patients with metastatic digestive cancer receiving Folfiri regimenPOUJOL, Sylvain; BRESSOLLE, Frangoise; DUFFOUR, Jacqueline et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 3, pp 292-305, issn 0344-5704, 14 p.Article

Cancer Risks Associated With Germline Mutations in MLH1, MSH2, and MSH6 Genes in Lynch SyndromeBONADONA, Valérie; BONAITI, Bernard; COLAS, Chrystelle et al.JAMA, the journal of the American Medical Association. 2011, Vol 305, Num 22, pp 2304-2310, issn 0098-7484, 7 p.Article

Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancerDUFFOUR, Jacqueline; GOURGOU, Sophie; DESSEIGNE, Francoise et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 3, pp 383-389, issn 0344-5704, 7 p.Article

A limited sampling strategy to estimate the pharmacokinetic parameters of irinotecan and its active metabolite, SN-38, in patients with metastatic digestive cancer receiving the FOLFIRI regimenPOUJOL, Sylvain; PINGUET, Frederic; YCHOU, Marc et al.Oncology reports. 2007, Vol 18, Num 6, pp 1613-1621, issn 1021-335X, 9 p.Article